Navigation Links
Jennerex Announces First Patient Treated in Phase 2a Clinical Trial of JX-594 as a Neoadjuvant Therapy in Colorectal Cancer Patients Undergoing Surgery
Date:12/21/2011

SAN FRANCISCO, Dec. 21, 2011 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver.

The study is being led by Rebecca Auer, M.D., surgical oncologist at The Ottawa Hospital, associate scientist at the Ottawa Hospital Research Institute and assistant professor of surgery at the University of Ottawa in Ottawa, Canada.  The clinical trial is being supported by funding from the Ontario Institute for Cancer Research­.

"This trial will allow us to evaluate the use of JX-594 in patients with surgically resectable disease, potentially expanding the role of this therapy in the treatment continuum," said David H. Kirn, M.D., president and chief medical officer of Jennerex.  "We continue to believe that JX-594 could play an integral role in the treatment of cancers and look forward to the results of this trial along with data from the larger Phase 2b study, called TRAVERSE, that is under way in patients with advanced hepatocellular carcinoma."

"In addition, this study will allow us to expand our analysis of the multi-mechanistic therapeutic activity of JX-594 through the examination of tumor specimens collected during surgery following JX-594 administration," said John C. Bell, Ph.D., senior scientist, cancer therapeutics, Ottawa Hospital Research Institute, and professor of medicine, University of Ottawa.  Dr. Bell is also the program leader of the Ontario Institute for Cancer Research's Immuno- and Bio-therapies Program.

This Phase 2a clinical trial will enroll approximately 20 patients with colorectal cancer metastases to the liver. Patients will receive a single
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
4. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
5. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
6. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
7. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
8. Jennerex Announces Presentations at Upcoming Conferences
9. Jennerex Appoints Gregory W. Schafer as Chief Financial Officer
10. Jennerex Appoints Lara Longpre to Chief Operating Officer
11. Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... , Dec. 12, 2014 HudsonAlpha ... the HiSeq X Ten sequencing system manufactured by ... HudsonAlpha to produce and analyze genomic data faster ... from the Institute,s commitment to research programs for ... HiSeq X Ten provides unprecedented capacity, speed and ...
(Date:12/13/2014)... 12, 2014 Research ... addition of the  "Global Capnography Market 2015-2019" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Capnography is the ... respiratory gasses during the integral part of ... information about CO2 production, alveolar ventilation, and ...
(Date:12/13/2014)...   Zacks Equity Research highlights MiMedx Group, Inc. (Nasdaq: ... Conn,s (Nasdaq: CONN - Free Report )  as the Bear of ... (Nasdaq: MYL - Free Report ), Pfizer (NYSE: PFE - ... ). Here is a synopsis of all five stocks: ... Bull of the Day comes from biomedical/genetics industry that currently ranks in ...
Breaking Medicine Technology:HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3Global Capnography Market 2015-2019: Key Vendors are Covidien, Masimo, Philips Healthcare, Smiths Medical and Welch Allyn 2Global Capnography Market 2015-2019: Key Vendors are Covidien, Masimo, Philips Healthcare, Smiths Medical and Welch Allyn 3MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day 2MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day 3MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day 4MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day 5MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day 6MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day 7
... VolitionRX Limited (VNRX.OB) ("Volition" or the "Company"), a life ... following letter to its shareholders from Cameron Reynolds, CEO: ... our company has been growing and the fact that we ... review the past year and look forward to future goals ...
... 2011 Menicon Holdings BV and Eye Shelter SA, ... independent ophthalmic group, announced on October 31 that Menicon ... the SOLO-care (R) contact lens solutions range in member ... The agreement will enable Menicon to significantly strengthen ...
Cached Medicine Technology:VolitionRX Limited Issues Update Letter to Shareholders 2VolitionRX Limited Issues Update Letter to Shareholders 3VolitionRX Limited Issues Update Letter to Shareholders 4VolitionRX Limited Issues Update Letter to Shareholders 5Menicon to Market Eye Shelter's SOLO-care (R) Contact Lens Solution Range in Europe and Canada 2
(Date:12/15/2014)... Pass, OR (PRWEB) December 15, 2014 ... perceived by United States women as impacting skin health ... the “Four C’s of skin care.” Water and health ... conclusions in a recent article describing the survey and ... experience, every item in every category discussed would benefit ...
(Date:12/15/2014)... 2014 South Florida’s leading urgent care provider, ... be a daze of hassle, hustle, and bustle that can ... halls, to burns when making special meals and heartburn after ... happen at any time. To prevent this season of joy ... a list of helpful and healthful holiday tips to keep ...
(Date:12/15/2014)... By Steven Reinberg ... -- A large, new study should reassure the millions of ... the risk for breast cancer. "There is no association ... Tamimi, an associate professor of medicine at Harvard Medical School. ... for concern, and there is no protective effect either." ...
(Date:12/15/2014)... Emergo Group, Inc., a medical device regulatory ... and South America, Europe, the Middle East, Asia and ... its 2015 Medical Device Industry Survey. Each year, Emergo ... and market trends as well as regulatory and operational ... including:, , Overall prospects for medical ...
(Date:12/15/2014)... Kenmode Precision Metal Stamping has announced ... of Quality Assurance. He brings more than 15 ... certifications for manufacturers in the U.S. and abroad. ... Manager at Sonoco Products Company in the Protective Solutions ... Quality Assurance Manager for Prince Industries, all in the ...
Breaking Medicine News(10 mins):Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2
... UK could help our leading athletics coaches deliver outstanding results ... , The SESAME ... video and body sensor technologies designed to aid the training ... combine these technologies into a unique, integrated computer system that ...
... Sept. 12 Inverness Medical,Innovations, Inc. (Amex: ... rapid,diagnostic products for the consumer and professional markets, ... Cholestech,Corporation (Nasdaq: CTEC ). Inverness completed the ... with and into Cholestech, after,Cholestech,s shareholders approved the ...
... series of mega events in,Hispanic communities around the country ... Awareness Month. The next major,Heart Health event in Chicago ... and 6:00 pm. The Festival de la Villita will ... at the,Health Supersite at 26th and Kostner in the ...
... Living Property for a ... Profit of $600,000 ... Board of Directors, SPRINGFIELD, Ohio, Sept. 12 AdCare Health,Systems, Inc., ... a Nevada corporation, today announced termination of a,certain definitive merger agreement previously ...
... the,country are encouraged to show their creativity by participating ... by the American,Academy of Allergy, Asthma & Immunology (AAAAI) ... million children in the United States have,asthma and it ... them from participating in activities they enjoy. The ...
... Sept. 12 Shopko announced today that,the company expects to ... stores will be located in the Appleton area. The,locations are ... Buchanan, WI, Ballard Road & Evergreen Drive Appleton, ... another step,forward in our overall growth plans. It also reinforces ...
Cached Medicine News:Health News:Advanced technologies aim to transform the coaching of top athletes 2Health News:Advanced technologies aim to transform the coaching of top athletes 3Health News:Inverness Completes Acquisition of Cholestech 2Health News:Inverness Completes Acquisition of Cholestech 3Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 2Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 3Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 4Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 5Health News:AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc. 2Health News:AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc. 3Health News:Kids, How Do You Manage Your Asthma? The AAAAI and AAP announce 17th annual poster contest 2Health News:Shopko Express Coming to the Fox Valley 2
... The ImmunoDOT TORCH Test is ... intended for determining the presence ... rubella virus, cytomegalovirus and herpes ... heparinized whole blood to indicate ...
... The Borrelia DotBlot G Tests are qualitative ... of Borrelia burgdorferi antibodies (IgG or IgM, ... from these tests should be supplemented with ... results can be used to support a ...
... The ImmunoDOT Autoimmunity Screening Panel ... test for screening and detection of ... (ANA, DNA, SS-A/SS-B, RNP/Sm) in serum, ... in the diagnosis of systemic lupus ...
The Invacare Pulse Oximeter provides fast, reliable SpO2 and pulse-rate measurements on any patient from infant to adult. It's designed for simple, accurate spot-checking and is a member of a full-li...
Medicine Products: